OurLadyJ

yes, it’s all about the money (but still i’m shocked every time). perhaps i am new here.

CNN Money Feb 27, 2007
This week, members of Big Pharma will lift the curtain on what could be the next generation of HIV drugs. Pfizer, Merck, Johnson & Johnson and the biotech Gilead Sciences are all planning to unveil study results on drugs that slow the spread of the AIDS virus in Los Angeles this week, at the Conference on Retroviruses and Opportunistic Infection. AIDS drugs might not have the blockbuster potential of drugs that treat cancer and heart disease, which afflict patients in the relatively affluent U.S. and European populations. About two-thirds of the approximately 40 million worldwide AIDS patients live in sub-Saharan Africa, and many are too poor to afford the thousands of dollars in annual costs for HIV anti-virals. But these drugs do serve as rich PR platforms for drug companies, which often give them away or sell them at reduced prices.